Blocking lactate: kick T cells when they are down
In the last couple of decades, cancer research has been shifting its focus to the immune system. Cancer cells, with their ability to adapt and evade immune responses, seem to accelerate the evolutionary pressure that has been put on our immune system during evolution. We thus try to aid these natural selection processes and assist our immune system to combat cancer. Here, we are discussing a study by Greg Delgoffe and colleagues that was published in <i>Nature Immunology</i> in December 2024, exploring a new approach to bring the dysfunctional immune cells back to life by blocking their lactate uptake.
Authors
- Dirk Brenner (ORCID: https://orcid.org/0000-0001-8979-1045)
- Bart Everts (ORCID: https://orcid.org/0000-0002-3764-5131)
- Veronika Horková (ORCID: https://orcid.org/0000-0002-3679-2236)
Institutions
- University of Southern Denmark (DK)
- University of Luxembourg (LU)
- Leiden University Medical Center (NL)
- Odense University Hospital (DK)
- Luxembourg Institute of Health (LU)
Publication Details
- Journal
- Immunometabolism
- Published
- 2025-03-19
- DOI
- https://doi.org/10.1097/in9.0000000000000059
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00